Bon Natural Life Limited (BON)
NASDAQ: BON · Real-Time Price · USD
1.123
+0.013 (1.17%)
At close: Feb 21, 2025, 4:00 PM
1.120
-0.003 (-0.27%)
After-hours: Feb 21, 2025, 6:03 PM EST
Company Description
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People’s Republic of China and internationally.
The company offers personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; and natural health supplements comprising powder drinks and bioactive food ingredient products used as food additives and nutritional supplements.
Its products are used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries.
Bon Natural Life Limited was founded in 2006 and is based in Xi'an, the People’s Republic of China.
Bon Natural Life Limited
Country | China |
Founded | 2006 |
IPO Date | Jun 24, 2021 |
Industry | Specialty Chemicals |
Sector | Materials |
Employees | 97 |
CEO | Yongwei Hu |
Contact Details
Address: Block C, Gazelle Valley, Room 601 Xi'an China | |
Website | bnlus.com |
Stock Details
Ticker Symbol | BON |
Exchange | NASDAQ |
Fiscal Year | October - September |
Reporting Currency | USD |
IPO Price | $5.00 |
CIK Code | 0001816815 |
CUSIP Number | G14492105 |
ISIN Number | KYG144921056 |
SIC Code | 2833 |
Key Executives
Name | Position |
---|---|
Yongwei Hu | Chairman and Chief Executive Officer |
Wang L. Lee | Chief Financial Officer |
Yingchun Xue | Chief Operating Officer |
Jianli Liu | Chief Technology Officer and Chief Scientist |
Wenjuan Chen | Chief Marketing Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Feb 18, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
Jan 28, 2025 | 20-F | Annual and transition report of foreign private issuers |
Jan 17, 2025 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
Jan 6, 2025 | 6-K | Report of foreign issuer |
Jan 3, 2025 | 6-K | Report of foreign issuer |
Dec 18, 2024 | 6-K | Report of foreign issuer |
Nov 19, 2024 | F-1 | Registration statement for certain foreign private issuers |
Oct 31, 2024 | DRS | [Cover] Draft Registration Statement |
Oct 29, 2024 | 6-K | Report of foreign issuer |
Oct 11, 2024 | 20-F/A | Filing |